A 13-Week, Randomized, Double-Blind, Multicenter, Placebo-Controlled Study Of Pregabalin For Postherpetic Neuralgia
Clinical trial NCT00394901 · COMPLETED
Trial details
- NCT number
- NCT00394901
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-09-01
- Primary completion
- 2007-11-01
- Enrollment
- 372
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.